A. Introduction Pfizer‚ US pharmaceutical company is one of the largest pharmaceutical companies in the world. Unfortunately‚ Pfizer faced challenges by macro-environment forces that affect their sales volume decline dramatically in 2011. PESTEL‚ Porter’s Five Forces and Industry Lift Cycle frameworks to be applied to analysis the broad macro-environment that affected Pfizer in the pharmaceutical industry. 1. PESTEL framework PESTEL (Appendix I) is classifies into six environmental influences
Premium Pharmaceutical industry Pharmacology Food and Drug Administration
Indian Pharmaceutical Industry Business Environment 3 Agenda • • • • • • • History Indian Pharmaceutical Evolution Facts and Figures Regulatory Framework Current ongoing activities SWOT Analysis The India Advantage 4 History • Bengal Chemicals and Pharmaceutical Works‚ Calcutta‚ the first Indian pharmaceutical company established in 1901 • Still exists as one of the 5 government owned drug manufacturers • Next 60 years saw most of the drugs imported from multinationals 5 History
Premium Pharmaceutical industry Pharmacology Clinical trial
The global pharmaceutical industry Introduction Pharmaceutical industry is the one of big revenue business in the world. There are lots of company gains a lot of profit and market share in this industry. Most of those companies were established in 19 century and early 20 century. This study explains their model development process of pharmaceutical industry‚ it details some issue like Thalidomide tragedy in 1970’s and legislation‚ then decreases the risk of side effect and protects the patient
Premium Economics Form of government Marketing
1. Overview of the global pharmaceutical industry In 2003‚ Britain’s Guardian newspaper commented that‚ “on the face of it‚ the global pharmaceutical industry looks like the epitome of a modern‚ mature industry that has found a comfortable way to make profits by the billion: it ’s global‚ hi-tech‚ and has the ultimate customer‚ the healthcare budgets of the world ’s richest countries.” Guardian sept 2003 The global pharmaceutical industry is nowadays made up of thousands of companies contained
Premium Generic drug Pharmaceutical industry Pharmacology
can move away from an economy that is an impressive underdog‚ to one that can truly join the ranks of the fastest growing economies in the region. Bangladesh has three key attractions for global investors and multinationals: a large base of low-cost labour‚ a large domestic market of 150mn people‚ and nearly 3bn people in the Asian region that it has market access to. The aim of this paper is to provide global investors with an outline on the challenges and prospects for the Bangladesh economy
Premium Investment
their long-term survival in the intensively competitive and high-stakes drug industry. Industry Analysis -Porter’s Five Forces The Pharmaceutical industry has several high entry barriers as shown in figure 1. Economies of scale‚ product differentiation‚ government policy and capital requirements and financial services are few barriers for new entrant. Level of threat from rivalry is also high in this industry. Industry has presence of large number of small firms of a similar size. They are in direct
Premium Marketing Pharmacology Steel
Table of Contents Table of Contents i Introduction 1 1 Definition of The Pharmaceutical Industry 1 2 Environmental Analysis 2 2.1 Legal Issues 2 2.2 Political Issues 2 2.3 Economic Issues 2 2.4 Social Issues 2 2.5 Technological Issues 2 3 Forces of Competition 3 4 Value Chain 4 4.1 Discovery 4 4.2 Production Development 4 4.3 Manufacturing 4 4.4 Marketing 4 5 Role of Information Systems & Technology 4 6 GlaxoSmithKline 5 7 United Drug 6 7.1 Company Overview
Premium Pharmaceutical industry Pharmacology Drug discovery
The Global Pharmaceutical Industry In the pharmaceutical industry market segments can be found depending on the criteria used. For example‚ geographically there are three main market segments (the Triad accounting for 80% and with the strongest growth): The United States of America‚ Europe and Japan with the main future segment being the least developed countries. Another way of classifying the market segments that the pharmaceutical industries face is by those products directed to primary care
Premium Pharmaceutical industry Pharmacology Generic drug
RFID in Pharmaceutical Industry In 2004‚ US Food and Drug Administration (FDA) has called for the implementation of RFID technology to track the distribution of prescription drugs in order to protect the medical supply chain from counterfeit drugs by 2007. Initially‚ California State Board of Pharmacy has mandated RFID technology but later extended implementation date until 2015. In 2007‚ Kalorama Information predicted in a report that market for RFID solutions in pharmaceutical industry would
Premium RFID Pharmacology Pharmaceutical industry
Jennifer Ambert Prof Weren Fall 12’ Tuesday 6p-8:40p MGT4600-61 Pfizer Case Study 1. Why has the pharmaceutical industry been so successful historically? The pharmaceutical industry has been such a successful industry for numerous reasons: • Patent protection is considered to be an incentive for investing‚ and also creates customer loyalty. • Generic brands have been profitable and cost efficient for buyers. This simply means that suppliers don’t need to offer a particular name brand; all
Premium Pharmacology Brand Patent